Pfizer employees in India can now avail 12-week paternity leave, the company announced this week, in a move to promote inclusion and diversity.
Biological as well adoptive fathers will benefit from the leave policy, which became applicable from January 1, 2023.
Over a two-year period, employees can avail maximum six weeks and minimum two weeks of leave in a single tranche, the global pharmaceutical giant announced.
Pfizer also offers its employees medical plans, including infertility treatments, and telemedicine facilities.
The company wants to enable both men and women to devote equal time to parenting, Shilpi Singh, Pfizer's director (people experience), said.
"We believe the future of a progressive workspace will be defined by practices that harness a people-first approach," she added. "The 12-week paternity leave policy will most certainly enable our male colleagues and their partners to cherish the experience and joyful moments of parenthood."
New York-headquartered Pfizer, along with German company BioNTech, has been at the forefront of COVID-19 vaccine development efforts. Currently, they are testing a combined vaccine for coronavirus and influenza vaccine.
Paternity leaves are increasingly becoming the norm at many workplaces, breaking the stereotype of childcare primarily being the mother's responsibility.
Given most urban families in India and nuclear, liberal leave policies help working parents handle childcare better.
Human resource consultants say famous fathers like Parag Agrawal and Virat Kohli opening up about parenting duties is helping the cause.
Also read: Paternity leave is gradually coming out of closet at workplace
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
